Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HUMANA INC
Report date September 30, 2024 · Filed September 30, 2024
Section 16 reporting ended · disclosed 2024-09-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Humana CommonSEC Table I · non-derivative | Direct | 11,723 |
Reported balance
Holding disclosure · report date 2024-09-30 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 11,723 F11: Includes 1,396 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. |
| Humana CommonSEC Table I · non-derivative | IndirectSee Footnote | 121 |
Reported balance
Holding disclosure · report date 2024-09-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 121 F1: Shares held for the benefit of reporting person as of August 31, 2024 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c). |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $307.97 · Expires 2026-02-25 | Direct | 324 |
Reported balance
Holding disclosure · report date 2024-09-30 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 324 F2: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 02/25/2019, vesting in three increments from 2/25/20 to 2/25/22. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $350.79 · Expires 2027-02-24 | Direct | 2,149 |
Reported balance
Holding disclosure · report date 2024-09-30 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 2,149 F3: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $376.61 · Expires 2028-02-22 | Direct | 4,807 |
Reported balance
Holding disclosure · report date 2024-09-30 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 4,807 F4: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $425.06 · Expires 2029-02-21 | Direct | 3,750 |
Reported balance
Holding disclosure · report date 2024-09-30 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 3,750 F5: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $510.24 · Expires 2030-02-24 | Direct | 3,698 |
Reported balance
Holding disclosure · report date 2024-09-30 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 3,698 F6: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $367.21 · Expires 2031-02-21 | Direct | 5,389 |
Reported balance
Holding disclosure · report date 2024-09-30 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 5,389 F7: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 345 |
Reported balance
Holding disclosure · report date 2024-09-30 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 345 F8: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 639 |
Reported balance
Holding disclosure · report date 2024-09-30 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 639 F8: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F10: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. |
| Phantom Stock UnitsSEC Table II · derivative / convertible security | IndirectSee Footnote | 24 |
Reported balance
Holding disclosure · report date 2024-09-30 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 24 F12: Phantom Stock Units held for the benefit of reporting person as of August 31, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held for the benefit of reporting person as of August 31, 2024 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).
F2: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 02/25/2019, vesting in three increments from 2/25/20 to 2/25/22.
F3: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.
F4: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.
F5: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.
F6: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
F7: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.
F8: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
F9: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
F10: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.
F11: Includes 1,396 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.
F12: Phantom Stock Units held for the benefit of reporting person as of August 31, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2024 Filed Feb 23, 2024 19:29 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 1,226 | $366.11 | $448,844.73 |
DisclosureSEC source: 0001062993-24-004189 · form4.xml · nonDerivative · entry 2 Fleming William Kevin · CIK 0001699801 · Chief Corporate Aff. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,327 F15 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/22/24. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 19:29 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 3,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004189 · form4.xml · nonDerivative · entry 1 Fleming William Kevin · CIK 0001699801 · Chief Corporate Aff. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,553 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · shares: Includes Performance Stock Units that are not required to be reported until vest. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 19:29 UTC | HUMANA INC HUM · Entity 1429 | GrantOptions · Derivative | 5,389 | $0.00 Strike: $367.21 | $0.00 |
DisclosureSEC source: 0001062993-24-004189 · form4.xml · derivative · entry 10 Fleming William Kevin · CIK 0001699801 · Chief Corporate Aff. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,389 Underlying: Humana Common · 5,389 shares Expires 2031-02-21 F7 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. F7 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 19:29 UTC | HUMANA INC HUM · Entity 1429 | GrantHumana Common | 1,396 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004189 · form4.xml · nonDerivative · entry 3 Fleming William Kevin · CIK 0001699801 · Chief Corporate Aff. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,723 F11 · shares: Restricted stock units granted to reporting person on 2/21/24. F12 · balance_after: Includes 1,396 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 15:48 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 319 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-022811 · form4.xml · derivative · entry 15 Fleming William Kevin · CIK 0001699801 · Chief Corporate Aff. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 639 Underlying: Humana Common · 319 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F11 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. F11 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 15:48 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 345 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-022811 · form4.xml · derivative · entry 14 Fleming William Kevin · CIK 0001699801 · Chief Corporate Aff. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 345 Underlying: Humana Common · 345 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F10 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F10 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 15:48 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-022811 · form4.xml · derivative · entry 13 Fleming William Kevin · CIK 0001699801 · Chief Corporate Aff. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 390 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 15:48 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 147 | $463.58 | $68,146.26 |
DisclosureSEC source: 0001062993-23-022811 · form4.xml · nonDerivative · entry 6 Fleming William Kevin · CIK 0001699801 · Chief Corporate Aff. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,987 F13 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Restricted Stock Units on 12/15/23. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 15:48 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 319 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-022811 · form4.xml · nonDerivative · entry 5 Fleming William Kevin · CIK 0001699801 · Chief Corporate Aff. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,134 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 15:48 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 159 | $463.58 | $73,709.22 |
DisclosureSEC source: 0001062993-23-022811 · form4.xml · nonDerivative · entry 4 Fleming William Kevin · CIK 0001699801 · Chief Corporate Aff. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,815 F13 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Restricted Stock Units on 12/15/23. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 15:48 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 345 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-022811 · form4.xml · nonDerivative · entry 3 Fleming William Kevin · CIK 0001699801 · Chief Corporate Aff. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 15:48 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 179 | $463.58 | $82,980.82 |
DisclosureSEC source: 0001062993-23-022811 · form4.xml · nonDerivative · entry 2 Fleming William Kevin · CIK 0001699801 · Chief Corporate Aff. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,629 F13 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Restricted Stock Units on 12/15/23. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 15:48 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-022811 · form4.xml · nonDerivative · entry 1 Fleming William Kevin · CIK 0001699801 · Chief Corporate Aff. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: 2,391 shares were transferred from William K. Fleming Grantor Retained Annuity Trust (est. 7/2/2020) to direct ownership on 9/15/2023. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 15:49 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 958 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005050 · form4.xml · derivative · entry 12 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 958 Underlying: Humana Common · 958 shares Expires not disclosed F8 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F11 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. F11 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 15:49 UTC | HUMANA INC HUM · Entity 1429 | GrantOptions · Derivative | 3,698 | $0.00 Strike: $510.24 | $0.00 |
DisclosureSEC source: 0001062993-23-005050 · form4.xml · derivative · entry 9 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,698 Underlying: Humana Common · 3,698 shares Expires 2030-02-24 F7 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. F8 · derivative.exercise_date: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 15:49 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 1,802 | $510.24 | $919,456.99 |
DisclosureSEC source: 0001062993-23-005050 · form4.xml · nonDerivative · entry 2 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,027 F14 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/24/23. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 15:49 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 4,560 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005050 · form4.xml · nonDerivative · entry 1 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · shares: Performance Stock Units vested on 2/24/23, not required to be reported until vest. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:36 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 345 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024068 · form4.xml · derivative · entry 15 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 690 Underlying: Humana Common · 345 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F10 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F10 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:36 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 389 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024068 · form4.xml · derivative · entry 14 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390 Underlying: Humana Common · 389 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:36 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 428 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024068 · form4.xml · derivative · entry 13 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 428 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:36 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 159 | $510.02 | $81,093.18 |
DisclosureSEC source: 0001062993-22-024068 · form4.xml · nonDerivative · entry 6 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,269 F12 · shares: Shares disposed of represent payment for tax liability on shares vesting 12/15/22, no value was received in return. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:36 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 345 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024068 · form4.xml · nonDerivative · entry 5 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:36 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 179 | $510.02 | $91,293.58 |
DisclosureSEC source: 0001062993-22-024068 · form4.xml · nonDerivative · entry 4 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,083 F12 · shares: Shares disposed of represent payment for tax liability on shares vesting 12/15/22, no value was received in return. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:36 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 389 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024068 · form4.xml · nonDerivative · entry 3 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:36 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 197 | $510.02 | $100,473.94 |
DisclosureSEC source: 0001062993-22-024068 · form4.xml · nonDerivative · entry 2 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,873 F12 · shares: Shares disposed of represent payment for tax liability on shares vesting 12/15/22, no value was received in return. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:36 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 428 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024068 · form4.xml · nonDerivative · entry 1 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 17:52 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionOptions · Derivative | 4,297 | $0.00 Strike: $350.79 | $0.00 |
DisclosureSEC source: 0001062993-22-021633 · form4.xml · derivative · entry 8 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,149 Underlying: Humana Common · 4,297 shares Expires 2027-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23. F4 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 17:52 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionOptions · Derivative | 6,860 | $0.00 Strike: $307.97 | $0.00 |
DisclosureSEC source: 0001062993-22-021633 · form4.xml · derivative · entry 7 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324 Underlying: Humana Common · 6,860 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 02/25/2019, vesting in three increments from 2/25/20 to 2/25/22. F3 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 02/25/2019, vesting in three increments from 2/25/20 to 2/25/22. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 17:52 UTC | HUMANA INC HUM · Entity 1429 | GiftHumana Common | 900 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-021633 · form4.xml · nonDerivative · entry 4 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,642 F13 · shares: Shares disposed of represent gift/charitable donation, effective November 3, 2022, in which no value was received in return. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 17:52 UTC | HUMANA INC HUM · Entity 1429 | SaleHumana Common | 11,157 | $565.61 | $6,310,550.94 |
DisclosureSEC source: 0001062993-22-021633 · form4.xml · nonDerivative · entry 3 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,542 F14 · price: Price reported is weighted average sales price. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 17:52 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 4,297 | $350.79 | $1,507,333.89 |
DisclosureSEC source: 0001062993-22-021633 · form4.xml · nonDerivative · entry 2 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,699 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 17:52 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 6,860 | $307.97 | $2,112,639.90 |
DisclosureSEC source: 0001062993-22-021633 · form4.xml · nonDerivative · entry 1 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2022 Filed May 2, 2022 17:34 UTC | HUMANA INC HUM · Entity 1429 | SaleHumana Common | 3,210 | $449.68 | $1,443,470.55 |
DisclosureSEC source: 0001062993-22-011163 · form4.xml · nonDerivative · entry 2 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 884 F13 · price: Price reported is weighted average sales price. Read SEC document |
| April 28, 2022 Filed May 2, 2022 17:34 UTC | HUMANA INC HUM · Entity 1429 | GiftHumana Common | 663 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-011163 · form4.xml · nonDerivative · entry 1 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,094 F12 · shares: Shares disposed of represent gift/charitable donation, effective April 28, 2022, in which no value was received in return. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:16 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 2,079 | $428.27 | $890,373.33 |
DisclosureSEC source: 0001062993-22-006100 · form4.xml · nonDerivative · entry 2 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,757 F13 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/25/22. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:16 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 5,289 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006100 · form4.xml · nonDerivative · entry 1 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · shares: Performance Stock Units vested on 2/25/22, not required to be reported until vest. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 23:09 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 1,035 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005413 · form4.xml · derivative · entry 10 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,035 Underlying: Humana Common · 1,035 shares Expires not disclosed F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F10 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F10 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 23:09 UTC | HUMANA INC HUM · Entity 1429 | GrantOptions · Derivative | 3,750 | $0.00 Strike: $425.06 | $0.00 |
DisclosureSEC source: 0001062993-22-005413 · form4.xml · derivative · entry 7 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Humana Common · 3,750 shares Expires 2029-02-21 F6 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. F6 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:43 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 389 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013071 · form4.xml · derivative · entry 14 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 779 Underlying: Humana Common · 389 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F10 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. F10 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:43 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 428 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013071 · form4.xml · derivative · entry 13 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428 Underlying: Humana Common · 428 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:43 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 542 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013071 · form4.xml · derivative · entry 12 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 542 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 2/25/19, 33% of the award is vesting on 12/15/19, 12/15/20 and 12/15/21. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 2/25/19, 33% of the award is vesting on 12/15/19, 12/15/20 and 12/15/21. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:43 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 179 | $459.85 | $82,313.15 |
DisclosureSEC source: 0001062993-21-013071 · form4.xml · nonDerivative · entry 6 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,547 Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:43 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 389 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013071 · form4.xml · nonDerivative · entry 5 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:43 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 197 | $459.85 | $90,590.45 |
DisclosureSEC source: 0001062993-21-013071 · form4.xml · nonDerivative · entry 4 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,337 Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:43 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 428 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013071 · form4.xml · nonDerivative · entry 3 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:43 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 249 | $459.85 | $114,502.65 |
DisclosureSEC source: 0001062993-21-013071 · form4.xml · nonDerivative · entry 2 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,106 Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:43 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 542 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013071 · form4.xml · nonDerivative · entry 1 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2021 Filed May 6, 2021 15:25 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionOptions · Derivative | 1,391 | $0.00 Strike: $271.14 | $0.00 |
DisclosureSEC source: 0000049071-21-000090 · edgar.xml · derivative · entry 9 Fleming William Kevin · CIK 0001699801 · Seg Pres, Clin & Phm Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 1,391 shares Expires 2025-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 03/1/2018, vesting in three increments from 2/19/19 to 2/19/21. F3 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 03/1/2018, vesting in three increments from 2/19/19 to 2/19/21. Read SEC document |
| May 04, 2021 Filed May 6, 2021 15:25 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionOptions · Derivative | 6,623 | $0.00 Strike: $268.47 | $0.00 |
DisclosureSEC source: 0000049071-21-000090 · edgar.xml · derivative · entry 8 Fleming William Kevin · CIK 0001699801 · Seg Pres, Clin & Phm Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 6,623 shares Expires 2025-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 02/19/2018, vesting in three increments from 2/19/19 to 2/19/21. F2 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 02/19/2018, vesting in three increments from 2/19/19 to 2/19/21. Read SEC document |
| May 04, 2021 Filed May 6, 2021 15:25 UTC | HUMANA INC HUM · Entity 1429 | SaleHumana Common | 1,257 | $459.74 | $577,892.68 |
DisclosureSEC source: 0000049071-21-000090 · edgar.xml · nonDerivative · entry 6 Fleming William Kevin · CIK 0001699801 · Seg Pres, Clin & Phm Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,862 F14 · price: Price reported is weighed avg sales price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.